We design our models to be modular and easy to develop/maintain. Our existing models can be expanded to incorporate new biology and to predict the efficacy of novel drugs.

  • Will a compound be efficacious for a specific indication?
  • What target engagement is required for the compound to be efficacious?
  • Will a developed compound be successful in another indication?
  • Would a combination approach improve efficacy?